Sol-Gel Technologies Inventory Turnover Ratio 2016-2023 | SLGL

Sol-Gel Technologies inventory turnover ratio from 2016 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Sol-Gel Technologies Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.026B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.930B 18.86
Aspen Pharmacare (APNHY) South Africa $4.985B 0.00
BridgeBio Pharma (BBIO) United States $4.477B 0.00
Bausch Health Cos (BHC) Canada $3.117B 2.43
Amphastar Pharmaceuticals (AMPH) United States $1.999B 13.68
Supernus Pharmaceuticals (SUPN) United States $1.639B 0.00
Taysha Gene Therapies (TSHA) United States $0.473B 0.00
Generation Bio (GBIO) United States $0.217B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00